Log In
Print this Print this

Human anthrax monoclonal antibody (Thravixa)

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionHuman anthrax mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationAnthrax
Indication DetailsTreat anthrax infection
Regulatory Designation EU - Orphan Drug (Treat anthrax infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today